Expression of the Stem Cell Markers Nestin and CD133 on Circulating Melanoma Cells

Beier, 2007, CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles, Cancer Res, 67, 4010, 10.1158/0008-5472.CAN-06-4180 Boiko, 2010, Human melanoma initiating cells express neural crest nerve growth factor receptor CD271, Nature, 466, 133, 10.1038/nature09161 Cohen, 2008, Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer, J Clin Oncol, 26, 3213, 10.1200/JCO.2007.15.8923 de Bono, 2008, Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer, Clin Cancer Res, 14, 6302, 10.1158/1078-0432.CCR-08-0872 Ehrmann, 2005, Nestin as a diagnostic and prognostic marker: immunohistochemical analysis of its expression in different tumors, J Clin Pathol, 58, 222, 10.1136/jcp.2004.021238 Fang, 2005, A tumorigenic subpopulation with stem cell properties in melanomas, Cancer, 65, 9328, 10.1158/0008-5472.CAN-05-1343 Flørenes, 1994, Expression of the neuroectodermal intermediate filament nestin in human melanoma, Cancer Res, 54, 354 Fusi, 2009, Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study), Eur J Cancer, 45, 3189, 10.1016/j.ejca.2009.09.004 Fusi, 2010, Stem cell marker nestin expression in peripheral blood of patients with melanoma, Br J Dermatol, 163, 107, 10.1111/j.1365-2133.2010.09779.x Grichnik, 2006, Melanoma, a tumor based on a mutant stem cell?, J Invest Dermatol, 126, 142, 10.1038/sj.jid.5700017 Haraguchi, 2008, CD133+CD44+ population efficiently enriches colon cancer initiating cells, Ann Surg Oncol, 15, 2927, 10.1245/s10434-008-0074-0 Harris, 2007, American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer, J Clin Oncol, 25, 5287, 10.1200/JCO.2007.14.2364 Hothorn, 2003, On the exact distribution of maximally selected rank, Stat Comput Stat Data Anal, 43, 121, 10.1016/S0167-9473(02)00225-6 Keilholz, 2004, Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction, Clin Cancer Res, 10, 1605, 10.1158/1078-0432.CCR-0610-3 Kelly, 2007, Tumor growth need not be driven by rare cancer stem cells, Science, 317, 337, 10.1126/science.1142596 Kennedy, 2007, Comment on ‘Tumor growth need not to be driven by rare cancer stem cells, Science, 318, 1722, 10.1126/science.1149590 Kitago, 2009, mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beads, Clin Chem, 55, 757, 10.1373/clinchem.2008.116467 Klein, 2009, Genetic heterogeneity of single disseminated tumor cells in minimal residual cancer, Lancet, 360, 683, 10.1016/S0140-6736(02)09838-0 Klein, 2007, Increased expression of stem cell markers in malignant melanoma, Mod Pathol, 20, 102, 10.1038/modpathol.3800720 Koyanagi, 2005, Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial, J Clin Oncol, 23, 8057, 10.1200/JCO.2005.02.0958 Mihic-Probst, 2007, Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma, Int J Cancer, 121, 1764, 10.1002/ijc.22891 Mocellin, 2006, The prognostic value of circulating tumor cells in patients with melanoma: a systemic review and meta-analysis, Clin Cancer Res, 12, 4605, 10.1158/1078-0432.CCR-06-0823 Monzani, 2007, Melanoma contains CD133 and ABCG2 positive cells with enhanced tumorigenic potential, Eur J Cancer, 43, 935, 10.1016/j.ejca.2007.01.017 Piras, 2010, The stem cell marker nestin predicts poor prognosis in human melanoma, Oncol Rep, 23, 17 Quintana, 2008, Efficient tumor formation by single human melanoma cells, Nature, 456, 593, 10.1038/nature07567 Quaglino, 2007, Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients, Melanoma Res, 17, 75, 10.1097/CMR.0b013e328054c667 Reya, 2001, Stem cells, cancer, and cancer stem cells, Nature, 414, 105, 10.1038/35102167 Riethdorf, 2007, Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system, Clin Cancer Res, 13, 920, 10.1158/1078-0432.CCR-06-1695 Roesch, 2010, A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth, Cell, 141, 583, 10.1016/j.cell.2010.04.020 Schatton, 2008, Identification of cells initiating human melanomas, Nature, 451, 345, 10.1038/nature06489 Singh, 2007, Cancer stem cells in nervous system tumors, Oncogene, 23, 7267, 10.1038/sj.onc.1207946 Singletary, 2003, Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual, Cancer, 98, 2740, 10.1002/cncr.11865 Suesskind, 2009, Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study Tewes, 2009, Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies, Breast Cancer Res Treat, 115, 581, 10.1007/s10549-008-0143-x Ulmer, 2008, Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma, Clin Cancer Res, 14, 4469, 10.1158/1078-0432.CCR-08-0012 Ulmer, 2004, Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells, Clin Cancer Res, 10, 531, 10.1158/1078-0432.CCR-0424-03 Wright, 2008, Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics, Breast Cancer Res, 10, R10, 10.1186/bcr1855 Yin, 2007, CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity, Int J Cancer, 120, 1444, 10.1002/ijc.22476